Cutting the Gordian Helix — Regulating Genomic Testing in the Era of Precision Medicine  

Oleh:

Lander, Eric S.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 372 no. 13 (Mar. 2015), page 1185-1186.

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

In his 2015 State of the Union address, President Barack Obama announced a new Precision Medicine Initiative (PMI), a national investment in research on approaches to disease treatment and prevention that take into account individual variability in each person's genes, environment, and lifestyle. In a recent Perspective article, Francis Collins and Harold Varmus sketched out initial ideas for the PMI research plans as envisioned by the National Institutes of Health (NIH).1 But scientific progress alone won't guarantee that the public reaps the full benefits of precision medicine — an achievement that, as Collins and Varmus note, “will also require advancing the nation's regulatory frameworks.”

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali